Asami Tetsu, Kaneko Hiroki, Miyake Kensaku, Ota Ichiro, Miyake Goichiro, Kato Seiichi, Yasuda Shunsuke, Iwase Takeshi, Ito Yasuki, Terasaki Hiroko
Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan ; Miyake Eye Hospital, Nagoya, Japan.
Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Transl Vis Sci Technol. 2016 Sep 30;5(5):9. doi: 10.1167/tvst.5.5.9. eCollection 2016 Sep.
We report a newly developed device to fragment thrombi in retinal vein occlusion.
The new instrument consists of a 23-gauge (G) pipe and a 37-G needle with an internal wire. A total of 40 porcine eyes were used; 20 eyes for experiments in the branch retinal vein (BRV group) and 20 eyes for experiments in the central retinal vein (CRV group). We placed 25-G 3-port trocars, and core vitrectomy was performed. Another 23-G scleral incision was performed for insertion of the needle. The needle pierced the retinal vein at a distance of three- to four- or one-disc diameters from the optic disc (BRV or CRV group, respectively), and the internal wire was advanced toward the disc. The success rates of needle piercing and cannulation of the internal wire were recorded in each group. In the CRV group, the cannulation was deemed successful when the tip reached inside the optic disc. Real-time optical coherence tomography imaging also was performed using the Zeiss Rescan 700 device in porcine eyes. Histologic examination of the retinal vessel inserted with the internal wire was performed.
The success rates of needle piercing into the BRV and CRV were 85% and 95%, respectively. The success rates of cannulation of the internal wire into the BRV and CRV were 85% and 0%, respectively. The process of cannulation was recorded successfully with the Rescan 700. Histologic examination showed no damages to the endothelial cell layer.
The needle and internal wire intended to be used for recanalization of BRV occlusion were successfully pierced and cannulated into the BRV.
This newly developed device could become a treatment modality for retinal vein occlusion to fragment thrombi that present treatment methods cannot reach and remove directly.
我们报告一种新开发的用于视网膜静脉阻塞中血栓碎裂的装置。
新仪器由一根23号(G)管道和一根带内部金属丝的37G针头组成。总共使用了40只猪眼;20只眼用于视网膜分支静脉实验(BRV组),20只眼用于视网膜中央静脉实验(CRV组)。我们置入25G三通道套管针,并进行了核心玻璃体切除术。另做一个23G巩膜切口用于插入针头。针头在距视盘三到四个视盘直径或一个视盘直径处(分别为BRV组或CRV组)穿刺视网膜静脉,内部金属丝向视盘推进。记录每组中针头穿刺和内部金属丝插管的成功率。在CRV组中,当尖端到达视盘内部时,插管被视为成功。还使用蔡司Rescan 700设备对猪眼进行了实时光学相干断层扫描成像。对插入内部金属丝的视网膜血管进行了组织学检查。
BRV和CRV的针头穿刺成功率分别为85%和95%。内部金属丝插入BRV和CRV的成功率分别为85%和0%。使用Rescan 700成功记录了插管过程。组织学检查显示内皮细胞层无损伤。
旨在用于BRV阻塞再通的针头和内部金属丝成功穿刺并插入BRV。
这种新开发的装置可能成为视网膜静脉阻塞的一种治疗方式,用于碎裂现有治疗方法无法直接触及和清除的血栓。